Compare Dolby Laboratories, Inc. (DLB) vs Microchip Technology Inc. (MCHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Microchip Technology Inc. — how do they compare? Dolby Laboratories, Inc. trades at $58.9 (market cap $5.47B), while Microchip Technology Inc. trades at $76.52 (market cap $41.01B). The key difference: Microchip Technology Inc. is far larger — about 7.5× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.46%). Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Microchip Technology Inc. for 62 Days on average.
| DLB | MCHP | |
|---|---|---|
Market Cap | $5.47B | $41.01B |
Volume | 1,058,284 | 9,972,516 |
Sector | Technology | Technology |
52-Week High | $70.09 | $102.97 |
52-Week Low | $48.51 | $49.02 |
Typical Hold Time | 98 Days | 62 Days |
Enterprise Value | $4.85B | $46.13B |
Dividend Yield | 2.46% | 2.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals. The company maintains strong profitability with 87.61% gross margins and has beaten earnings estimates for three consecutive quarters. Recent developments include expanded partnerships with Meta and leadership transition to new CEO Marc Whitten. Cash flow improved significantly in 2025 with $472M operating cash flow.
DLB presents a mixed outlook with strong fundamentals but technical weakness. The 47% upside to $90.33 consensus target offers potential, though near-term execution risks and licensing volatility remain concerns. Revenue stability around $1.3B and premium valuation metrics require continued innovation execution to justify current multiples.
Microchip Technology (MCHP) trades at $78.02, down 3.99% on the day, amid a bearish technical signal. The stock has beaten earnings estimates for the last three quarters, with Q3 2026 results pending. Revenue declined sharply in 2025 to $4.40B, resulting in a net loss, but 2026 projections show recovery. Analyst consensus is strongly bullish with a $110.50 price target. Recent news highlights expansion in Ethernet and power portfolios, plus the acquisition of Hailo to bolster edge AI capabilities.
MCHP's outlook is supported by robust analyst buy ratings and exposure to growing AI and data center demand. However, high valuation multiples, significant debt, and cyclical semiconductor risks pose challenges. Earnings growth in 2026 will be critical to justifying its premium valuation and driving shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →
